Source: StreetInsider

Press Release: Elevar Therapeutics : Elevar Therapeutics Announces the Formation and Members of Scientific Advisory Board

Scientific Advisory Board formed with internationally recognized liver and biliary tract cancer physicians to support the advancement of solid tumor pipeline...

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Kate Flavin McKinley's photo - CEO of Elevar Therapeutics

CEO

Kate Flavin McKinley

CEO Approval Rating

- -/100

Read more